Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the management of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://theresasxlj374807.ka-blogs.com/92197880/semaglutide-a-potential-solution-for-metabolic-disorders